Similarly, the MDM2 rs937282 polymorphism has been linked to lung cancer [38] and breast cancer [61], while MDM2 rs937283 has been implicated in retinoblastoma [62], oral cancer [32], thyroid cancer [63], breast cancer [61,64,65], gastric cancer [66], and liver cancer [65]. This evidence concerns the gene MDM2 and thyroid gland carcinoma.